NATCO Pharma Ltd on Tuesday said its consolidated net profit for the quarter ended September 30 was down by over 35 per cent to Rs 117.7 crore against Rs 181. 6 crore in the same quarter last fiscal.
The city-based rug maker in a press release said the company recorded consolidated total revenue of Rs 518.9 Crore for the second quarter against Rs 583.50 Crore for the same period last year.
"The decline in revenues and profits compared to the same period last year is primarily due to the anticipated drop in oseltamivir product sales in the USA and Hep C sales in India," it said.
The Board of Directors has recommended second interim dividend of Rs 1.00 per equity share of Rs 2.00 each.
Disclaimer: No Business Standard Journalist was involved in creation of this content
